This growing problem is being addressed, but most GLP-1 agonists will require prior authorization from the patients insurance company
"Our decision to prefer Wegovy over Zepbound will deliver significant cost savings for our clients in this therapy class, and the lower net price we were able to negotiate for Wegovy will enable more employers to provide coverage for the weight loss category," CVS Health Vice President of External Affairs David Whitrap told IndyStar in a written statement
Its one of the key topics covered in our new white paper, GLP-1 and Weight Management: What Employee Behavior Reveals About Sustainable Obesity Care, along with: Reframing obesity as a chronic disease, not a willpower problem The changing treatment landscape and how employees are using GLP-1s The crucial role of behavioral support Strategies for long-term obesity care, backed by data from Levantos Healthy Weight program Read the white paper and put a more comprehensive weight management plan into action
SAH, a form of CVD, has been linked to lactylation modification, in addition to its occurrence in brain parenchyma